Skip to content

Arterial Blood Filter BF-37

by Delta Medical Industries 510(k)

Active United States

510(k) K802755

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK802755 Date7 Jan 1981ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
DTM
Device Class
Class II
Regulation
21 CFR Part 870.4260
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Arterial Blood Filter BF-37 is a cardiopulmonary bypass arterial line blood filter (Device Type: Filter, Blood, Cardiopulmonary Bypass, Arterial Line), designed to remove nonbiologic particles and emboli—such as blood clots or foreign material—from arterial blood during extracorporeal circulation. It functions as part of a gas exchange (oxygenator) system to ensure the filtered blood is free of obstructive debris before re-entry into the patient’s circulation.

This device is intended for single-use in controlled clinical settings, such as operating rooms during cardiothoracic procedures. Supplied sterile and classified as a Class II device under FDA regulation 870.4260, it is supplied in a sterile package and must be handled under aseptic conditions. The BF-37 model is authorized via FDA 510(k) clearance (K802755) and is intended for use in non-MRI environments. Storage requires adherence to manufacturer guidelines to maintain sterility and functionality.

Other devices from Delta Medical Industries

See all devices from Delta Medical Industries →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What clinical procedures is the Arterial Blood Filter BF-37 designed to support during use in cardiopulmonary bypass systems?

    The BF-37 is specifically designed for use during cardiothoracic procedures where extracorporeal circulation is required, such as open-heart surgeries. It filters arterial blood to remove nonbiologic particles and emboli (e.g., clots or foreign material) before the blood is reintroduced into the patient’s circulation, ensuring safer perfusion during bypass.

  • Is the Arterial Blood Filter BF-37 intended for reuse, or is it strictly single-use?

    The BF-37 is explicitly intended for single-use only in controlled clinical settings like operating rooms. It is supplied sterile and must be handled under aseptic conditions to prevent contamination, which aligns with its classification as a Class II device under FDA regulation 870.4260.

  • How should the BF-37 be stored to maintain its sterility and functionality?

    The device must be stored according to the manufacturer’s guidelines to preserve sterility and performance. Since it is supplied sterile in its packaging, it should remain unopened until use and kept in a clean, dry environment away from direct sunlight or extreme temperatures, as per Delta Medical Industries’ recommendations.

  • Can the Arterial Blood Filter BF-37 be used in environments where MRI scans are performed?

    No, the BF-37 is not intended for use in MRI environments. The device’s design and materials are not compatible with magnetic resonance imaging, as explicitly noted in its regulatory documentation.

  • What type of regulatory clearance does the BF-37 hold, and how was it determined?

    The BF-37 holds FDA 510(k) clearance (K802755) under the Traditional review pathway, with a decision of *Substantially Equivalent* (SESE) to a predicate device. This classification was determined by the FDA’s Cardiovascular (CV) Advisory Committee, confirming its compliance with safety and effectiveness standards for blood filters used in cardiopulmonary bypass systems.